The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes.
Gynecol. Oncol., Jun;125(3):531-5 (2012)
Impact of operative start time on surgical outcomes in patients undergoing primary cytoreduction for advanced ovarian cancer.
Gynecol. Oncol., Jul;126(1):58-63 (2012)
A prospective study of the feasibility and acceptability of a Web-based, electronic patient-reported outcome system in assessing patient recovery after major gynecologic cancer surgery.
Gynecol. Oncol., Aug (2012)
The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered?
Int. J. Gynecol. Cancer., Apr;21(3):511-6 (2011)
Establishing a sentinel lymph node mapping algorithm for the treatment of early cervical cancer.
Gynecol. Oncol., Aug;122(2):275-80 (2011)
An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT).
Gynecol. Oncol., Jan;124(1):10-4 (2012)
Pleural effusion detected at CT prior to primary cytoreduction for stage III or IV ovarian carcinoma: effect on survival.
Radiology., Mar;258(3):776-84 (2011)
The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma.
Gynecol. Oncol., Dec;123(3):548-52 (2011)
Pelvic exenteration with curative intent for recurrent uterine malignancies.
Gynecol. Oncol., Jan;124(1):42-7 (2012)
Recovery issues of fertility-preserving surgery in patients with early-stage cervical cancer and a model for survivorship: the physician checklist.
Int. J. Gynecol. Cancer., Jan;21(1):106-16 (2011)
Sentinel lymph node biopsy in the management of early-stage cervical carcinoma.
Gynecol. Oncol., Mar;120(3):347-52 (2011)
Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for uterine or cervical cancers.
Gynecol. Oncol., Nov;119(2):208-11 (2010)
Pathologic analysis of ex vivo plasma energy tumor destruction in patients with ovarian or peritoneal cancer.
Int. J. Gynecol. Cancer., Nov;20(8):1326-30 (2010)
The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum.
Gynecol. Oncol., Mar;116(3):351-7 (2010)
Complex atypical hyperplasia of the uterus: characteristics and prediction of underlying carcinoma risk.
Am. J. Obstet. Gynecol., Oct;203(4):349.e1-6 (2010)
The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas.
Gynecol. Oncol., Oct;119(1):38-42 (2010)
Radical abdominal trachelectomy for stage IB1 cervical cancer at 15-week gestation.
Gynecol. Oncol., Jan;116(1):151-2 (2010)
Video-assisted thoracic surgery (VATS) evaluation of pleural effusions in patients with newly diagnosed advanced ovarian carcinoma can influence the primary management choice for these patients.
Gynecol. Oncol., Mar;116(3):483-8 (2010)
Improving sentinel lymph node detection rates in endometrial cancer: how many cases are needed?
Gynecol. Oncol., Dec;115(3):453-5 (2009)
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm.
Gynecol. Oncol., Jul;114(1):26-31 (2009)